VNRX
This biotech firm focuses on developing innovative diagnostic tests for various diseases, particularly cancer. Utilizing proprietary epigenetic technology, it aims to detect illnesses early through simple blood samples. Its research spans multiple conditions, including colorectal and lung cancers, with a goal to revolutionize non-invasive diagnostics. The company collaborates with global institutions to advance its scientific breakthroughs and bring accessible testing solutions to healthcare markets.
Name | CIK | Position |
---|---|---|
loading... |